Limited operation for severe multisegmental bilateral bronchiectasis

Murris, Marlène; Didier, A.; Giron, J.; Dahan, M.; Berjaud, J.; Léophonte, P.

doi:10.1016/s0003-4975(02)04322-9

Cited by 31 publications

(30 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Maziéres et al [36] observed that a total disappearance or regression of preoperative symptoms occurred in 75% of such patients. In a recent study [38], the authors suggest that surgery for bilateral NCFB can be performed with morbidity and mortality patterns quite similar to those results in localized disease, with a disappearance or regression of preoperative symptoms in 83% of patients.…”

Section: Antimicrobial Therapymentioning

confidence: 98%

“…In addition, the preoperative treatment should include reducing airway obstruction and eliminating microorganisms from the lower respiratory tract, therefore consisting of antimicrobial therapy, postural physiotherapy, bronchodilators and corticosteroids. The presence of multiple or bilateral NCFB is generally considered to be a contraindication to operation [36]. Surgery for bilateral NCFB is considered risky, and hemorrhagic or infectious complication are expected because of the bronchial arterial circulation and septic context.…”

Section: Antimicrobial Therapymentioning

confidence: 99%

“…Surgery for bilateral NCFB is considered risky, and hemorrhagic or infectious complication are expected because of the bronchial arterial circulation and septic context. However, some groups [37] have proposed radical operations for bilateral NCFB, although others have reported higher operative mortality [36]. It seems that limited operations should be offered to some patients with diffuse NCFB.…”

Section: Antimicrobial Therapymentioning

confidence: 99%

See 2 more Smart Citations

Non-cystic fibrosis bronchiectasis

Neves

Guerra

Ponce

et al. 2011

Interactive CardioVascular and Thoracic Surgery

View full text Add to dashboard Cite

Bronchiectasis is characterized by irreversible widening of the medium-sized airways, with inflammation, chronic bacterial infection and destruction of the bronchial walls. Exercise or inspiratory muscle training may improve quality of life and exercise endurance in people with non-cystic fibrosis bronchiectasis. Prolonged-use antibiotics improve clinical response rates, but may not reduce exacerbation rates or lung function. Surgery is often considered for people with extreme damage to one or two lobes of the lung who are at risk for severe infection or bleeding. In this review, the authors will focus on non-cystic fibrosis bronchiectasis, pointing out the differences in management when compared with the cystic fibrosis context, with special emphasis on surgical management.

show abstract

Section: Antimicrobial Therapymentioning

confidence: 98%

Section: Antimicrobial Therapymentioning

confidence: 99%

Section: Antimicrobial Therapymentioning

confidence: 99%

See 1 more Smart Citation

Non-cystic fibrosis bronchiectasis

Neves

Guerra

Ponce

et al. 2011

Interactive CardioVascular and Thoracic Surgery

View full text Add to dashboard Cite

show abstract

“…From the end of the 1970s, some surgeons have been suggesting that bilateral bronchiectases might not contraindicate resection. 2,[6][7][8][9][10][11][12][13][14][15][16][17][18] We preformed pulmonary function studies in all patients. In some series, it was found to be normal in patients with localized bronchiectasis, but in those with severe bronchiectasis, a mixed obstructive and restrictive pattern with hypoxemia has been observed.…”

Section: Discussionmentioning

confidence: 99%

“…[8][9][10] The presence of multiple or bilateral bronchiectases is generally regarded as a contraindication to operate. [11][12][13] This retrospective study reviews our surgical experience and results of treatment of 29 patients with bilateral bronchiectases during an 11-year period.…”

Section: Introductionmentioning

confidence: 99%

Surgical Management of Bilateral Bronchiectases: Results in 29 Patients

Aghajanzadeh

Sarshad²,

Amani

et al. 2006

Asian Cardiovasc Thorac Ann

View full text Add to dashboard Cite

Bronchiectasis is a major cause of morbidity and mortality in developing countries. Staged bilateral segmental resection of the lungs is performed in selected patients. Our experience of surgical removal of 87 bilateral bronchiectases in 29 patients during an 11-year period was reviewed retrospectively. High-resolution computed tomography was performed preoperatively in all patients to locate the anatomic sites of bronchiectasis. The mortality and morbidity of the surgical procedure, clinical symptoms, age distribution, etiology, bacteriology, and operative procedures were analyzed. There were 22 males (76%) and 7 females (24%), aged 5 to 60 years, with a mean age of 30 years. Complications developed in 11 patients (38%); atelectasia was the most common (14%). There was one hospital death. Clinical symptoms disappeared in 19 (66%) patients, improved in 5 (17%), and were unchanged in 4 (14%). Staged bilateral resection for bronchiectases can be performed at any age with acceptable morbidity and mortality.

show abstract

Bronchiectasis

Kolbe¹

2005

Evidence‐based Respiratory Medicine

View full text Add to dashboard Cite

Limited operation for severe multisegmental bilateral bronchiectasis

Cited by 31 publications

References 20 publications

Non-cystic fibrosis bronchiectasis

Non-cystic fibrosis bronchiectasis

Surgical Management of Bilateral Bronchiectases: Results in 29 Patients

Bronchiectasis

Contact Info

Product

Resources

About